Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Fisher

Showing results (291-300 of 304) with videos related to

Pageof 31
Sort By:
JAMA|May 8, 2026
Intravenous Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hours: The TNK-PLUS Randomized Clinical TrialYunyun Xiong, Fengyuan Che, Hao Wang, et al.
Lancet (London, England)|February 8, 2025
Normobaric hyperoxia combined with endovascular treatment for acute ischaemic stroke in China (OPENS-2 trial): a multicentre, randomised, single-blind, sham-controlled trialWeili Li, Jing Lan, Ming Wei, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 5, 2023
World Stroke Organization Brain & hEart globAl iniTiative ProgramLuciano A Sposato, Sheila Martins, Jan F Scheitz, et al.
Ebiomedicine|February 13, 2026
Effect of IL-6 receptor inhibition on infarct volume after endovascular treatment for ischaemic stroke: a phase 2, randomised, placebo-controlled trialXuehong Chu, Jing Lan, Zhengfei Ma, et al.
The Lancet. Neurology|November 10, 2022
Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in ChinaChengbei Hou, Jing Lan, Yinan Lin, et al.
The New England Journal of Medicine|June 17, 2024
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without ThrombectomyYunyun Xiong, Bruce C V Campbell, Lee H Schwamm, et al.
Lancet (London, England)|February 8, 2026
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trialYunyun Xiong, Fana Alemseged, Zhixin Cao, et al.
AJNR. American Journal of Neuroradiology|May 15, 2008
Acute stroke imaging research roadmapMax Wintermark, Gregory W Albers, Andrei V Alexandrov, et al.
Stroke|April 12, 2008
Acute stroke imaging research roadmapMax Wintermark, Gregory W Albers, Andrei V Alexandrov, et al.
Nature|October 13, 2012
A call for transparent reporting to optimize the predictive value of preclinical researchStory C Landis, Susan G Amara, Khusru Asadullah, et al.
Pageof 31

Showing results (291-300 of 304) with videos related to

Sort By:
Pageof 31
JAMA|May 8, 2026
Intravenous Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hours: The TNK-PLUS Randomized Clinical TrialYunyun Xiong, Fengyuan Che, Hao Wang, et al.
Lancet (London, England)|February 8, 2025
Normobaric hyperoxia combined with endovascular treatment for acute ischaemic stroke in China (OPENS-2 trial): a multicentre, randomised, single-blind, sham-controlled trialWeili Li, Jing Lan, Ming Wei, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 5, 2023
World Stroke Organization Brain & hEart globAl iniTiative ProgramLuciano A Sposato, Sheila Martins, Jan F Scheitz, et al.
Ebiomedicine|February 13, 2026
Effect of IL-6 receptor inhibition on infarct volume after endovascular treatment for ischaemic stroke: a phase 2, randomised, placebo-controlled trialXuehong Chu, Jing Lan, Zhengfei Ma, et al.
The Lancet. Neurology|November 10, 2022
Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in ChinaChengbei Hou, Jing Lan, Yinan Lin, et al.
The New England Journal of Medicine|June 17, 2024
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without ThrombectomyYunyun Xiong, Bruce C V Campbell, Lee H Schwamm, et al.
Lancet (London, England)|February 8, 2026
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trialYunyun Xiong, Fana Alemseged, Zhixin Cao, et al.
AJNR. American Journal of Neuroradiology|May 15, 2008
Acute stroke imaging research roadmapMax Wintermark, Gregory W Albers, Andrei V Alexandrov, et al.
Stroke|April 12, 2008
Acute stroke imaging research roadmapMax Wintermark, Gregory W Albers, Andrei V Alexandrov, et al.
Nature|October 13, 2012
A call for transparent reporting to optimize the predictive value of preclinical researchStory C Landis, Susan G Amara, Khusru Asadullah, et al.
Pageof 31